DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Compugen Ltd. (CGEN)
« Back to company indexCGEN Chatter Timeline
Stock Ticker for CGEN
Most Active Tweeters for CGEN
| User | Tweets |
|---|---|
| @reurope_stock | 3 |
| @whatsonthorold2 | 3 |
| @bibeypost_stock | 3 |
| @theflynews | 2 |
| @TickerReport | 2 |
Recent Tweets for CGEN
 |
@EnterpriseLeade Neurocrine Biosciences $NBIX vs. Compugen $CGEN Head-To-Head Analysis https://t.co/P845qezBcY July 15th 2018, 5:07pm |
 |
@AmericanBanking Comparing Neurocrine Biosciences $NBIX and Compugen $CGEN https://t.co/flfzLqqOel #stocks July 15th 2018, 5:07pm |
 |
@MareaInformativ Comparing Neurocrine Biosciences $NBIX and Compugen $CGEN https://t.co/8lW4K6GXWb July 15th 2018, 5:07pm |
 |
@bibeypost_stock What's Propelling Compugen Ltd. $CGEN to Increase So Much? - https://t.co/jckBdQhExT July 15th 2018, 4:07pm |
 |
@reurope_stock What Will Happen to Compugen Ltd. $CGEN Next? The Stock Just Increased A Lot https://t.co/9dg98QFI3T July 15th 2018, 4:07pm |
 |
@mmahotstuff1 Compugen Ltd. $CGEN on Focus After Raising In Today's Session - https://t.co/gYm1Iy9vhh July 15th 2018, 4:07pm |
 |
@whatsonthorold2 Could Compugen Ltd. $CGEN Rise Even More? The Stock Had Another Big Increase Today - https://t.co/3rO0kAVdYo July 15th 2018, 4:07pm |
 |
@ledgerzette Compugen $CGEN and Genocea Biosciences $GNCA Head to Head Survey https://t.co/h4WESyqCSF July 15th 2018, 2:07pm |
 |
@dakotafinancial Compugen $CGEN Downgraded by Zacks Investment Research to Sell https://t.co/NCOZPYrUBp July 15th 2018, 4:07am |
 |
@TickerReport Zacks Investment Research Downgrades Compugen $CGEN to Sell https://t.co/MJ7s1RtZKx July 15th 2018, 2:07am |
 |
@LiveCoinWatch @cgennetwork now listed on Live Coin Watch ? Click to track $CGEN LIVE | https://t.co/qM5qy8etIX https://t.co/oaHiRpj33n July 12th 2018, 2:07pm |
 |
@TheMarketsDaily Zacks Investment Research Downgrades Compugen $CGEN to Sell https://t.co/pRNGI2lcGg July 12th 2018, 3:07am |
 |
@TranscriptDaily Compugen $CGEN Lowered to “Sell” at Zacks Investment Research https://t.co/9xhZ8ePuYk July 11th 2018, 6:07am |
|
@bibeypost_stock Analysts See $-0.18 EPS for Compugen Ltd. $CGEN - https://t.co/r01B9ulrCe July 10th 2018, 7:07pm |
|
@reurope_stock EPS for Compugen Ltd. $CGEN Expected At $-0.18 https://t.co/U5yjL9VKI8 July 10th 2018, 7:07pm |
 |
@The_CasualSmart Compugen Ltd. $CGEN EPS Estimated At $-0.18 https://t.co/xPAgiwEdI2 July 10th 2018, 7:07pm |
|
@whatsonthorold2 Compugen Ltd. $CGEN Analysts See $-0.18 EPS - https://t.co/oWOLVaXpof July 10th 2018, 7:07pm |
|
@The_CasualSmart $-0.18 EPS Expected for Compugen Ltd. $CGEN https://t.co/O79SgtF5iK July 10th 2018, 7:07pm |
 |
@mulder_anke RT @BioWorld: $CGEN gets FDA green light for two INDs based on computer prediction tech, believed a #biopharma industry first July 10th 2018, 5:07am |
 |
@BioWorld $CGEN gets FDA green light for two INDs based on computer prediction tech, believed a #biopharma industry first July 10th 2018, 1:07am |
|
@bibeypost_stock EPS for Compugen Ltd. $CGEN Expected At $-0.18 - https://t.co/jkBW1mKxXj July 4th 2018, 10:07pm |
|
@reurope_stock Compugen Ltd. $CGEN Analysts See $-0.18 EPS https://t.co/K7GEPXGhZp July 4th 2018, 10:07pm |
|
@whatsonthorold2 Compugen Ltd. $CGEN Analysts See $-0.18 EPS - https://t.co/nlaBHkSNj2 July 4th 2018, 10:07pm |
|
@TickerReport Compugen $CGEN Sees Strong Trading Volume https://t.co/YkzPy8NKlp July 4th 2018, 9:07am |
 |
@LifeSciHealthIL $CGEN Oppenheimer repeats outperform on Compugen as the Israeli biotech has two candidates cleared for clinic… https://t.co/9iDTAtQtBZ July 3rd 2018, 3:07am |
 |
@Bear_Fabs RT @ShortTrades: small scalp on $CGEN nd nailed $ADMP for my first 2/3 of my position then brokeeven on last 1/3 as it didnt want to fade m… July 2nd 2018, 11:07pm |
 |
@ThisLincolnian Compugen $CGEN Sees Strong Trading Volume https://t.co/ize8bWCiy4 July 2nd 2018, 8:07pm |
 |
@bdailystocks FDA Removes Clinical Hold on $CGEN 's investigational new drug application for first-in-class immuno-oncology thera… https://t.co/fYZN9sA8z2 July 2nd 2018, 5:07pm |
 |
@proactive_NA $CGEN Oppenheimer repeats outperform on Compugen as the Israeli biotech has two candidates are cleared for clinic… https://t.co/8gYl00iXeo July 2nd 2018, 3:07pm |
 |
@TipRanksFeed 4-star analyst Mark Breidenbach from Oppenheimer maintained a Buy on $CGEN. https://t.co/1khWUL2okx July 2nd 2018, 2:07pm |
 |
@ShortTrades small scalp on $CGEN nd nailed $ADMP for my first 2/3 of my position then brokeeven on last 1/3 as it didnt want to… https://t.co/uYm0i7XLdM July 2nd 2018, 2:07pm |
 |
@StockNewsNow $CGEN Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic… https://t.co/4wQ5WAJUdk July 2nd 2018, 11:07am |
|
@StockNewsNow $CGEN Compugen Welcomes FDA Clearance of Bayer's IND Application for BAY 1905254 https://t.co/hZmoJyeG5t July 2nd 2018, 11:07am |
 |
@AllStar_Trading $CGEN Also stopped out at 3.60 July 2nd 2018, 9:07am |
 |
@NewsQuantified $CGEN shares jump as FDA lifts clinical hold on cancer treatment application, stock increases +1.47%, #Compugen https://t.co/w3otjwJJ9U July 2nd 2018, 9:07am |
 |
@StocksThatGo $CGEN Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody July 2nd 2018, 9:07am |
 |
@sep_sal RT @theflynews: Compugen shares jump as FDA lifts clinical hold on cancer treatment application $CGEN $BAYRY https://t.co/SaMS8spWnf July 2nd 2018, 9:07am |
 |
@Briefingcom $CGEN: Compugen: FDA has removed the clinical hold on its IND application for COM701 and informed the Company it ma… https://t.co/5BOCVAbdI9 July 2nd 2018, 9:07am |
 |
@ChuckMik $CGEN (+15.2% #premarket) Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology T… https://t.co/fLmdO9c8lS July 2nd 2018, 9:07am |
 |
@OpenOutcrier $CGEN (+15.2% pre) Compugen Ltd. (CGEN) Stock: Headed Up On FDA News https://t.co/KabBr0CV7Y July 2nd 2018, 8:07am |
 |
@theflynews Compugen shares jump as FDA lifts clinical hold on cancer treatment application $CGEN $BAYRY https://t.co/SaMS8spWnf July 2nd 2018, 8:07am |
 |
@teebizy RT @shaneblackmon: $CGEN up 12% on FDA removing clinical hold on it's IND, COM701, and FDA clearance of Bayer's IND BAY 1905254 July 2nd 2018, 8:07am |
 |
@StaticTrades $CGEN Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody July 2nd 2018, 8:07am |
 |
@market_sniper Shorting 100 shares of $CGEN at 3.95 but only 50 shares fill, I would rather be a chicken than roasted BBQ pork. https://t.co/oK88GbZTap July 2nd 2018, 8:07am |
 |
@HectorTrades RT @theflynews: Compugen: FDA removes clinical hold on IND application for COM701 $CGEN https://t.co/AJxmpW3hP0 July 2nd 2018, 7:07am |
 |
@WingTrades $CGEN up 20% on $FDA clearance July 2nd 2018, 7:07am |
 |
@trader_to_be $CGEN small scalp, but with some profit $ https://t.co/cN9lOF8xyr July 2nd 2018, 7:07am |
 |
@MarketCurrents Bayer on go with clinical development of Compugen-discovered therapeutic antibody https://t.co/ePyNIEuZXQ #premarket $CGEN $BAYRY July 2nd 2018, 7:07am |
 |
@shaneblackmon $CGEN up 12% on FDA removing clinical hold on it's IND, COM701, and FDA clearance of Bayer's IND BAY 1905254 July 2nd 2018, 7:07am |
 |
@DonnaYoungDC RT @BioStocks: $CGEN FDA removes clinical hold on IND application for COM701 https://t.co/mCCjmIsjYT July 2nd 2018, 7:07am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.